Long-term follow-up outcomes in a real-world study cohort after percutaneous patent foramen ovale closure.
Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, cilt.49, ss.29-39, 2020 (ESCI, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 49
- Basım Tarihi: 2020
- Doi Numarası: 10.5543/tkda.2020.06699
- Dergi Adı: Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.29-39
- Anahtar Kelimeler: Occluder device, patent foramen ovale, Risk of Paradoxi-cal Embolism score, INTRACARDIAC ECHOCARDIOGRAPHIC GUIDANCE, SECONDARY STROKE PREVENTION, ATRIAL SEPTAL-DEFECTS, DEVICE CLOSURE, CRYPTOGENIC STROKE, MEDICAL THERAPY, TRANSTHORACIC ECHOCARDIOGRAPHY, COMPLETION, MIGRAINE, TRIAL
- Hacettepe Üniversitesi Adresli: Evet
Özet
Objective: In recent years, percutaneous closure of a patent foramen ovale (PFO) has gained widespread use. This study is an evaluation of the safety and efficacy of the Figulla and Amplatzer devices for PFO closure, including long-term follow-up results.